CI stock icon

Cigna
CI

$339.98
0.62%
 

About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.

Employees: 72,500

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 22 analysts
0
News positive %
of 10 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

32% more funds holding in top 10

Funds holding in top 10: 31 [Q4 2023] → 41 (+10) [Q1 2024]

18% more capital invested

Capital invested by funds: $76.1B [Q4 2023] → $89.5B (+$13.5B) [Q1 2024]

11% more first-time investments, than exits

New positions opened: 174 | Existing positions closed: 157

1% more funds holding

Funds holding: 1,588 [Q4 2023] → 1,605 (+17) [Q1 2024]

8% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.3B

2.56% less ownership

Funds ownership: 86.96% [Q4 2023] → 84.39% (-2.56%) [Q1 2024]

12% less repeat investments, than reductions

Existing positions increased: 531 | Existing positions reduced: 603

Research analyst outlook

22 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$334
2%
downside
Avg. target
$382
12%
upside
High target
$435
28%
upside

22 analyst ratings

20 positive
91%
neutral
9%
negative
0%
Cantor Fitzgerald
Sarah James
18%upside
$400
Overweight
Reiterated
12 Jun 2024
JP Morgan
Lisa Gill
28%upside
$435
Overweight
Maintained
30 May 2024
Baird
Michael Ha
14%upside
$388
Outperform
Initiated
30 May 2024
Cantor Fitzgerald
Sarah James
18%upside
$400
Overweight
Maintained
3 May 2024
Oppenheimer
Michael Wiederhorn
18%upside
$400
Outperform
Maintained
3 May 2024

Financial journalist opinion

Based on 10 articles about CI published over the past 30 days